Flc Capital Advisors Johnson & Johnson Transaction History

Flc Capital Advisors

$430 Million
Q3 2024

A detailed history of Flc Capital Advisors transactions in Johnson & Johnson stock. As of the latest transaction made, Flc Capital Advisors holds 11,822 shares of JNJ stock, worth $1.83 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

11,822

Previous 11,788 0.29%

Holding current value

$1.83 Million

Previous $1.72 Million 11.21%

% of portfolio

0.45%

Previous 0.43%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$145.48 - $167.38 $4,946 - $5,690	34 Added 0.29%	11,822 $1.92 Million
Q2 2024 Jul 15, 2024	SELL	$144.38 - $157.78 $41,581 - $45,440	-288 Reduced 2.38%	11,788 $1.72 Million
Q1 2024 May 03, 2024	SELL	$155.22 - $162.74 $196,818 - $206,354	-1,268 Reduced 9.5%	12,076 $1.91 Million
Q4 2023 Jan 18, 2024	SELL	$145.6 - $158.88 $23,732 - $25,897	-163 Reduced 1.21%	13,344 $2.09 Million
Q3 2023 Jan 18, 2024	SELL	$155.75 - $174.48 $64,636 - $72,409	-415 Reduced 2.98%	13,507 $2.1 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $61,740 - $66,444	-400 Reduced 2.79%	13,922 $2.3 Million
Q1 2023 Apr 26, 2023	SELL	$151.05 - $180.26 $180,051 - $214,869	-1,192 Reduced 7.68%	14,322 $2.22 Million
Q4 2022 Jan 27, 2023	SELL	$160.2 - $179.79 $126,237 - $141,674	-788 Reduced 4.83%	15,514 $2.74 Million
Q3 2022 Oct 14, 2022	SELL	$161.33 - $179.52 $127,128 - $141,461	-788 Reduced 4.61%	16,302 $2.66 Million
Q2 2022 Jul 27, 2022	BUY	$168.19 - $186.01 $6,223 - $6,882	37 Added 0.22%	17,090 $3.03 Million
Q4 2021 Jan 26, 2022	SELL	$155.93 - $173.01 $32,121 - $35,640	-206 Reduced 1.19%	17,053 $2.92 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $80,377 - $86,219	-504 Reduced 2.84%	17,259 $2.84 Million
Q1 2021 Apr 23, 2021	BUY	$153.07 - $170.48 $5,663 - $6,307	37 Added 0.21%	17,763 $2.92 Million
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $53,610 - $61,535	391 Added 2.26%	17,726 $2.79 Million
Q3 2020 Oct 23, 2020	SELL	$140.38 - $153.83 $76,787 - $84,145	-547 Reduced 3.06%	17,335 $2.51 Million
Q2 2020 Jul 10, 2020	BUY	$128.81 - $155.51 $360,410 - $435,116	2,798 Added 18.55%	17,882 $2.56 Million
Q1 2020 Apr 09, 2020	BUY	$111.14 - $153.99 $909,125 - $1.26 Million	8,180 Added 118.48%	15,084 $2.01 Million
Q4 2019 Jan 13, 2020	SELL	$127.5 - $146.44 $128,392 - $147,465	-1,007 Reduced 12.73%	6,904 $1.01 Million
Q3 2019 Oct 29, 2019	SELL	$126.95 - $142.14 $146,500 - $164,029	-1,154 Reduced 12.73%	7,911 $1.02 Million
Q2 2019 Aug 05, 2019	BUY	$131.15 - $144.24 $126,822 - $139,480	967 Added 11.94%	9,065 $1.28 Million
Q1 2019 May 13, 2019	BUY	$125.72 - $139.79 $430,339 - $478,501	3,423 Added 73.22%	8,098 $1.13 Million
Q4 2018 Feb 11, 2019	BUY	$122.84 - $147.84 $574,277 - $691,152	4,675 New	4,675 $603,000

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Flc Capital Advisors with notifications on news.

Account

Flc Capital Advisors Johnson & Johnson Transaction History